Sciandra M;Marino MT;Manara MC;Guerzoni C;Grano M;Oranger A;Lucarelli E;Lollini PL;Dozza B;Pratelli L;Renzo MF;Colombo MP;Picci P;Scotlandi K, CD99 drives terminal differentiation of osteosarcoma cells by acting as a spatial regulator of ERK 1/2., «JOURNAL OF BONE AND MINERAL RESEARCH», 2014, 29, pp. 1295 - 1309 [articolo]
Zucchini C;Manara MC;Pinca RS;De Sanctis P;Guerzoni C;Sciandra M;Lollini PL;Cenacchi G;Picci P;Valvassori L;Scotlandi K, CD99 suppresses osteosarcoma cell migration through inhibition of ROCK2 activity., «ONCOGENE», 2014, 33, pp. 1912 - 1921 [articolo]
Amaral, A.T.A.; Manara, M.C.; Berghuis, D.; Ordonez, J.L.; Biscuola, M.; Lopez-Garcia, M.A.; Osuna, D.; Lucarelli, E.; Alviano, F.; Lankester, A.; Scotlandi, K.; De Alava, E., Characterization of human mesenchymal stem cells from Ewing sarcoma patients. Pathogenetic implications, «PLOS ONE», 2014, 9, pp. 1 - 9 [articolo]Open Access
Contaldo C;Myers TJ;Zucchini C;Manara MC;Chiodoni C;Colombo MP;Nicoletti G;Lollini PL;Li T;Longobardi L;Scotlandi K;Spagnoli A, Expression levels of insulin receptor substrate-1 modulate the osteoblastic differentiation of mesenchymal stem cells and osteosarcoma cells., «GROWTH FACTORS», 2014, 32, pp. 41 - 52 [articolo]
Wang, Z.; Zhu, B.; Zhang, M.; Parikh, H.; Jia, J.; Chung, C.C.; Sampson, J.N.; Hoskins, J.W.; Hutchinson, A.; Burdette, L.; Ibrahim, A.; Hautman, C.; Raj, P.S.; Abnet, C.C.; Adjei, A.A.; Ahlbom, A.; Albanes, D.; Allen, N.E.; Ambrosone, C.B.; Aldrich, M.; Amiano, P.; Amos, C.; Andersson, U.; Gerald Andriole, G.A., Jr.; Andrulis, I.L.; Arici, C.; Arslan, A.A.; Austin, M.A.; Baris, D.; Barkauskas, D.A.; Bassig, B.A.; Freeman, L.E.B.; Berg, C.D.; Berndt, S.I.; Bertazzi, P.A.; Biritwum, R.B.; Black, A.; Blot, W.; Boeing, H.; Boffetta, P.; Bolton, K.; Boutron-Ruault, M.-C.; Bracci, P.M.; Brennan, P.; Brinton, L.A.; Brotzman, M.; Bueno-de-Mesquita, H.B.; Buring, J.E.; Butler, M.A.; Cai, Q.; Cancel-Tassin, G.; Canzian, F.; Cao, G.; Caporaso, N.E.; Carrato, A.; Carreon, T.; Carta, A.; Chang, G.-C.; Chang, I.-S.; Chang-Claude, J.; Che, X.; Chen, C.-J.; Chen, C.-Y.; Chen, C.-H.; Chen, C.; Chen, K.-Y.; Chen, Y.-M.; Chokkalingam, A.P.; Chu, L.W.; Clavel-Chapelon, F.; Colditz, G.A.; Colt, J.S.; Con, Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33, «HUMAN MOLECULAR GENETICS», 2014, 23, pp. 6616 - 6633 [articolo]
Marino, M.T.; Grilli, A.; Baricordi, C.; Manara, M.C.; Ventura, S.; Pinca, R.S.; Bellenghi, M.; Calvaruso, M.; Mattia, G.; Donati, D.; Tripodo, C.; Picci, P.; Ferrari, S.; Scotlandi, K., Prognostic significance of miR-34a in Ewing sarcoma is associated with cyclin D1 and ki-67 expression, «ANNALS OF ONCOLOGY», 2014, 25, pp. 2080 - 2086 [articolo]
Garofalo, C; Capristo, M; Manara, Mc; Mancarella, C; Landuzzi, Lorena; Belfiore, A; Lollini, PIER LUIGI; Picci, Piero; Scotlandi, Katia, Metformin as an adjuvant drug against pediatric sarcomas: hypoxia limits therapeutic effects of the drug., «PLOS ONE», 2013, 8, pp. 1 - 12 [articolo]Open Access
Dozza B.; Papi A.; Lucarelli E.; Scotlandi K.; Pierini M.; Tresca G.; Donati D.; Orlandi M., Cell growth inhibition and apoptotic effect of the rexinoid 6-OH-11-O-hydroxyphenantrene on human osteosarcoma and mesenchymal stem cells., «TOXICOLOGY IN VITRO», 2012, 26, pp. 142 - 149 [articolo]
Garofalo, Cecilia; Mancarella, Caterina; Grilli, Andrea; Manara, MARIA CRISTINA; Astolfi, Annalisa; Marino, Maria Teresa; Conte, Alexia; Sigismund, Sara; Carã, Alessandra; Belfiore, Antonino; Picci, Piero; Scotlandi, Katia, Identification of common and distinctive mechanisms of resistance to different anti-IGF-IR agents in Ewing's sarcoma, «MOLECULAR ENDOCRINOLOGY», 2012, 26, pp. 1603 - 1616 [articolo]
Nakatani F.; Ferracin M.; Manara M.C.; Ventura S.; del Monaco V.; Ferrari S.; Alberghini M.; Grilli A.; Knuutila S.; Schaefer K.L.; Mattia G.; Negrini M.; Picci P.; Serra M.; Scotlandi K., miRNA signature predicts survival of Ewing’s sarcoma patients and miR34a directly influences cell chemosensitivity and malignancy, «JOURNAL OF PATHOLOGY», 2012, 226, pp. 796 - 805 [articolo]
TRIPODO C;SANGALETTI S;GUARNOTTA C;PICCALUGA P.;CACCIATORE M;GIULIANO M;FRANCO G;CHIODONI C;SCIANDRA M;MIOTTI S;CALVARUSO G;CARE' A;FLORENA AM;SCOTLANDI K;ORAZI A;PILERI SA;COLOMBO MP., Stromal SPARC contributes to the detrimental fibrotic changes associated with myeloproliferation whereas its deficiency favors myeloid cell expansion., «BLOOD», 2012, 120, pp. 3541 - 3554 [articolo]
Gasparre G; Kurelac I; Capristo M; Iommarini L; Ghelli A; Ceccarelli C; Nicoletti G; Nanni P; De Giovanni C; Scotlandi K; Betts CM; Carelli V; Lollini PL; Romeo G; Rugolo M; Porcelli AM, A Mutation Threshold Distinguishes the Antitumorigenic Effects of the Mitochondrial Gene MTND1, an Oncojanus Function, «CANCER RESEARCH», 2011, 71, pp. 6220 - 6229 [articolo]
Mattioli E; Columbaro M; Capanni C; Maraldi NM; Cenni V; Scotlandi K; Marino MT; Merlini L; Squarzoni S; Lattanzi G., Prelamin A-mediated recruitment of SUN1 to the nuclear envelope directs nuclear positioning in human muscle., «CELL DEATH AND DIFFERENTIATION», 2011, 18, pp. 1305 - 1315 [articolo]
D. Zambelli; M. Zuntini; F. Nardi; M.C. Manara; M. Serra; L. Landuzzi; P.-L. Lollini; S. Ferrari; M. Alberghini; A. Llombart-Bosch; E. Piccolo; S. Iacobelli; P. Picci; K. Scotlandi., Biological indicators of prognosis in Ewing’s sarcoma: an emerging role for lectin galactoside-binding soluble 3 binding protein (LGALS3BP)., «INTERNATIONAL JOURNAL OF CANCER», 2010, 126, pp. 41 - 52 [articolo]
P. Nanni; G. Nicoletti; L. Landuzzi; S. Croci; A. Murgo; A. Palladini; A. Antognoli; M.L. Ianzano; V. Stivani; V. Grosso; S.-M. Maira; C. García-Echeverría; K. Scotlandi; C. De Giovanni; P.-L. Lollini, High metastatic efficiency of human sarcoma cells in Rag2/gamma c double knockout mice provides a powerful test system for antimetastatic targeted therapy, «EUROPEAN JOURNAL OF CANCER», 2010, 46, pp. 659 - 668 [articolo]
